top of page
Blog: Blog2

Parenteral Nutrition Market Industry Clusters and Forecast to 2033

  • Writer: kiran aggarwal
    kiran aggarwal
  • Sep 19, 2025
  • 3 min read

Parenteral Nutrition Market Overview

Parenteral nutrition refers to the administration of essential nutrients directly into the bloodstream for patients who cannot meet their nutritional requirements through oral or enteral routes. This therapy is critical for individuals with gastrointestinal disorders, cancer, premature birth, or surgical complications where nutrient absorption is impaired. By providing carbohydrates, amino acids, lipids, vitamins, and minerals intravenously, parenteral nutrition ensures patient survival, recovery, and improved clinical outcomes. It is an indispensable component of modern critical care, oncology, neonatology, and gastroenterology.

Current Size & Growth Rate

According to Straits Research, the global parenteral nutrition market size was valued at USD 7.38 billion in 2024 and is projected to grow from USD 7.78 billion in 2025 to USD 11.85 billion by 2033, expanding at a CAGR of 5.4% during 2025–2033. This growth reflects increasing healthcare demand for specialized nutrition therapies across diverse patient populations.

Growth Drivers

The growth of the parenteral nutrition market is propelled by several key factors:

  • Rising Incidence of Chronic and Critical Illnesses: Conditions such as cancer, Crohn’s disease, short bowel syndrome, and gastrointestinal failure are driving the demand for parenteral nutrition in both hospital and home care settings.

  • Premature Birth Rates: The global rise in preterm births has significantly increased the need for neonatal parenteral nutrition to support growth and development.

  • Advancements in Formulations: Development of multi-chamber bags, safer lipid emulsions, and customized nutrient solutions is enhancing clinical efficiency and patient safety.

  • Growth in Homecare Nutrition: Increasing preference for home-based parenteral nutrition due to improved infusion technologies and reduced hospital stays is expanding market reach.

  • Improved Healthcare Access in Emerging Markets: Expanding healthcare infrastructure and rising awareness in regions such as Asia-Pacific and Latin America are accelerating adoption.

Key Competitors in the Parenteral Nutrition Market

  1. Baxter International Inc.

  2. Braun Melsungen AG

  3. Fresenius Kabi AG

  4. Otsuka Pharmaceutical

  5. Merck KGaA

  6. Grifols, S.A.

  7. Sichuan Kelun

  8. Vifor Pharma

Market Segmentation

By Nutrient Type:

  • Carbohydrates – Primary energy source in formulations.

  • Parenteral Lipid Emulsion – Supplies essential fatty acids and calories.

  • Single Dose Amino Acid Solution – Supports protein synthesis and tissue repair.

  • Trace Elements – Micronutrients essential for enzymatic and metabolic functions.

  • Vitamins and Minerals – Critical for immune support, recovery, and overall metabolic balance.

Key Trends & Innovations

  • Shift Toward All-in-One Nutrition Bags – Simplifying administration and reducing infection risk.

  • Focus on Patient-Specific Customization – Tailored formulations to address unique clinical needs.

  • Lipid Emulsion Innovations – Next-generation emulsions with better safety and tolerance profiles.

  • Home Infusion Growth – Technology-driven portable infusion devices enabling home-based care.

  • Sustainability in Manufacturing – Increasing adoption of eco-friendly packaging and production practices.

Regional Performance & Market Share

  • North America dominates the global market due to advanced healthcare infrastructure, strong presence of key players, and higher adoption of homecare nutrition.

  • Europe follows closely, driven by government initiatives, rising elderly populations, and focus on clinical nutrition programs.

  • Asia-Pacific is projected to be the fastest-growing region, supported by expanding healthcare access, higher neonatal care investments, and growing prevalence of chronic diseases.

  • Latin America and Middle East & Africa are gradually adopting parenteral nutrition therapies, with potential growth fueled by improving healthcare systems and rising medical tourism.

Challenges / Restraints

  • High cost of formulations and infusion devices.

  • Risk of complications such as infections, metabolic imbalances, and liver dysfunction.

  • Dependence on hospital infrastructure in certain regions, limiting accessibility.

  • Regulatory complexities for product approval and quality compliance.

Strategic Outlook & Future Implications

The parenteral nutrition market is on a steady growth path, supported by innovations in formulations, increasing adoption of home-based therapies, and rising clinical demand across oncology, neonatology, and critical care. Strategic implications include:

  • Investment in R&D for safer, more efficient multi-nutrient formulations.

  • Expansion into emerging markets with cost-effective, scalable solutions.

  • Collaboration with hospitals and homecare providers to enhance accessibility.

  • Focus on patient safety with infection-control innovations and real-time monitoring solutions.

The future of the market lies in personalized, technology-enabled, and patient-centric nutrition strategies that bridge hospital and homecare seamlessly.

About Straits Research

Straits Research delivers industry-leading analysis and intelligence across multiple sectors, empowering businesses, investors, and strategists with the data they need to make informed decisions. Our team of analysts combines rigorous research methodologies with deep market understanding to provide actionable insights and forecasts.

Contact:🌐 Website: https://straitsresearch.com/📧 Email: sales@straitsresearch.com🏢 Address: Siddhi Tower, Office C & D, 4th Floor, Pune


 
 
 

Recent Posts

See All
サービスタイプ別・製品タイプ別に見る世界のバイオ医薬品CDMO市場分析および2033年までの予測

バイオ医薬品業界は、生物製剤が医薬品開発パイプラインと治療法の革新において引き続き主導的な役割を果たす中、変革期を迎えています。この進化するエコシステムにおいて、生物製剤受託開発製造機関(CDMO)は、複雑な生物製剤の開発、製造、販売を支援する専門サービスを提供することで、極めて重要な役割を担っています。Straits Researchは、生物製剤CDMO市場に関する詳細な分析を提供し、この高付加

 
 
 
製品タイプ別・用途別に見る世界のカンナビジオール(CBD)市場分析および2033年までの予測

世界のカンナビジオール(CBD)市場は、消費者の認知度向上、規制当局の承認、そして製品イノベーションの加速に伴い、複数の産業で需要が急増しており、急速な拡大を見せています。大麻植物由来の非精神活性化合物であるCBDは、その潜在的な治療効果と、医薬品から食品・飲料まで幅広い用途における汎用性から、広く人気を集めています。Straits Researchは、この急成長市場について、主要なトレンド、推進

 
 
 
薬局自動化機器市場の成長要因、課題、機会および2033年までの予測

世界の薬局自動化機器市場は、医療システムが業務効率の向上、投薬ミスの削減、患者安全の強化のために先進技術をますます導入するにつれ、力強い成長を遂げています。医薬品業務の複雑化と処方箋数の増加に伴い、自動化は病院薬局と一般薬局の両方において不可欠な要素になりつつあります。Straits Researchは、この進化する市場に関する包括的な洞察を提供し、主要なトレンド、成長要因、および競争動向を明らか

 
 
 

Comments


bottom of page